2022
The Medical Community’s Evolving Focus on Physician and Surgeon Pregnancy: Thematic Trends From a Scoping Review
Hanchuk S, Casilla-Lennon M, Zheng S, Kim DD, Press B, Nguyen JV, Grimshaw A, Leapman MS, Rickey LM, Cavallo JA. The Medical Community’s Evolving Focus on Physician and Surgeon Pregnancy: Thematic Trends From a Scoping Review. Academic Medicine 2022, 97: 1071-1078. PMID: 35171119, PMCID: PMC9247020, DOI: 10.1097/acm.0000000000004629.Peer-Reviewed Original ResearchConceptsPhysician pregnancyMulti-institutional prospective observational studyDefinitive evidence-based recommendationsMaternal-fetal health outcomesProspective observational studyImpact of pregnancyEvidence-based recommendationsFull-text reviewOvid EmbaseCochrane LibraryPhysician specialtyObservational studyOvid MEDLINEInclusion criteriaStudy populationPregnancyHealth outcomesPhysiciansCommunity studySurgical specialtiesGoogle ScholarWork productivityWomen physiciansScoping ReviewPublication year
2021
Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies
Tran AN, Wang M, Hundt M, Chugh R, Ohm J, Grimshaw A, Ciarleglio M, Hung KW, Proctor DD, Price CC, Laine L, Al-Bawardy B. Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies. Journal Of Immunotherapy 2021, 44: 325-334. PMID: 34380976, DOI: 10.1097/cji.0000000000000383.Peer-Reviewed Original ResearchMeSH KeywordsAdrenal Cortex HormonesBiological ProductsColitisDiarrheaHumansImmune Checkpoint InhibitorsIncidenceNeoplasmsObservational Studies as TopicConceptsImmune checkpoint inhibitorsDiarrhea/colitisICI therapyCheckpoint inhibitorsObservational studyAnti-programmed cell death-1/Outcomes of ICISystematic reviewCell death-1/Permanent ICI discontinuationReal-world incidenceRemission of diarrheaRecurrence of symptomsDeath-1/Treatment of diarrheaRandom-effects modelICI discontinuationAdvanced malignanciesAppropriate patientsPrimary outcomeOverall incidenceAntigen-4Early treatmentColitisHigh risk